This page lists all pharmaceutical reports related to the field of Immunology & Inflammatory Diseases. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 215 results
- Commercial Insight: Asthma and COPD
- Stakeholder Insight: Osteoarthritis - COX-2s wear down traditional NSAID use
- Stakeholder Insight: Rheumatoid Arthritis - DMARDs Gain Ground as Biologics Competition Intensifies
- Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There Life After Claritin?
- Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics
- Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share
- Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage Pipeline Leaves Innovation to
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics
- The Worldwide Market for Prescription Dermatological Drugs - 4th Edition
- Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
- Gene Expression Profiling Markets
- Organ Transplant Immunosuppressive Markets
- The World Dermatological Market Analysis & Forecasts 2007-2022
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Inflammatory Bowel Disease - Debate over early aggressive treatment continues
- How to Conduct Clinical Trials in China
- Prescription Dermatological Drugs: Worldwide Market
- Worldwide Market for Rheumatoid Arthritis and Lupus Treatments
- Alpha 1 Antitrypsin Deficiency
- Commercial Insight: Autoimmune Diseases - Market continues to prosper
- Launching Combination Products: Brand extension and franchise development strategies
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Portable Inhaler Devices - Current Market and Life Cycle Opportunities
- Outsourcing in Drug Discovery
- World OTC Pharmaceutical Markets
- World Wound Care Markets 2008 - Burns, Skin Ulcers, Surgical and Trauma Wounds
- Respiratory Market Insight 2008
- The osteoarthritis market - COX-2 inhibibitors, NSAIDs and corticosteroids
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- World Wound Care Markets 2008
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- World Market for Respiratory Equipment and Disposables
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma
- Asthma/COPD - Little long-term future for long-acting single-agent inhalers
- Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments
- Stakeholder Opinions: Vaccine adjuvants